News
- Author:
- Ted Bosworth
Publish date: November 21, 2023
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Audio
- Author:
- Ted Bosworth
Publish date: November 21, 2023
Results of the head-to-head TEAMMATE trial show the combination of everolimus and low-dose tacrolimus can be considered an alternative to MMF plus ...
News
- Author:
- Ted Bosworth
Publish date: November 20, 2023
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.
News
- Author:
- Ted Bosworth
Publish date: November 16, 2023
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing ...
News
- Author:
- Ted Bosworth
Publish date: November 14, 2023
In patients with obesity, dual energy cardioversion is more reliable and just as safe as conventional single energy cardioversion as an initial str...
News
- Author:
- Ted Bosworth
Publish date: November 13, 2023
“At the highest doses, lepodisiran is not just lowering Lp(a), it appears to be getting rid of it.”
News
- Author:
- Ted Bosworth
Publish date: November 13, 2023
“I can say with confidence on the basis of a placebo-controlled trial that PCI certainly does have a favorable impact in patients with documented a...
News
- Author:
- Ted Bosworth
Publish date: November 10, 2023
Given the expanding array of therapies, the message of considering prurigo nodularis in Black patients in order to accelerate the time to diagnosis...
News
- Author:
- Ted Bosworth
Publish date: November 7, 2023
New guidelines for body dysmorphic disorder are designed to facilitate diagnosis and choice of intervention.
News
- Author:
- Ted Bosworth
Publish date: October 31, 2023
Already approved in adolescents and adults, topical ruxolitinib was found safe and effective in children.
News
- Author:
- Ted Bosworth
Publish date: October 13, 2023
Optimism is high about improving the survival and care of ALS patients. Neurologists who don’t specialize in ALS can add to the positivity by endor...
News
- Author:
- Ted Bosworth
Publish date: September 18, 2023
“What went wrong? Was it the drugs, the trial, or both?”
News
- Author:
- Ted Bosworth
Publish date: September 6, 2023
The guidelines are the ESC’s first major comprehensive attempt to address diagnosis and treatment of the broad causes of heart muscle dysfunction.<...
News
- Author:
- Ted Bosworth
Publish date: September 5, 2023
“I think many of us involved in pacing thought for many years that minimizing pacing would be beneficial, and this clearly shows it is not.”
News
- Author:
- Ted Bosworth
Publish date: August 28, 2023
The ESC-invited discussant called the outcome “remarkable” and a validation for “the millions of people” who are already taking qiliqiangxin in Chi...
